Orthofix Realigns Business Units to Support Future Growth Opportunities and Announces Leadership Changes (press release)
Orthofix International N.V., (NASDAQ:OFIX) (the Company) today announced the realignment of its businesses in order to better focus on operational performance and enhance the Company's growth potential. The Company's operational businesses will now include: BioStim (stimulation products), Spine Fixation (spine implant products), Biologics (biologics products for all applications), International Extremity Fixation, and U.S. Extremity Fixation (orthopedic fixation systems).
In...
Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.
Hit the SUBSCRIBE button at the top of the homepage.